SHOWING 1-10 OF 59 REFERENCES
Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer
Reconciliation of an equity adjustment procedure using proportional shortfall." Pharmacoeconomics
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada.
- European journal of cancer
Reconciliation of economic concerns and health policy
Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall
- Medicine, Economics
- The European Journal of Health Economics
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
- Clinical therapeutics
Discounting future health benefits: the poverty of consistency arguments.
- Economics, Medicine
- Health economics
Ethics and effectiveness: rationing healthcare by thresholds of minimum effectiveness
- BMJ : British Medical Journal